Acarix accelerates US commercialization into 30 additional states
Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced a strategic sales partnership with CompleMed, LLC, a nat...
Study published in Heart strengthens diagnostic value of Acarix CADScor System
Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced the release of a new study published in the March 2023 i...
Acarix presents at Redeye: Commercialization Seminar
On March 7 at 10.30 CET Helen Ljungdahl Round, CEO of Acarix, presents the latest developments in the company at Redeye.
Acarix to showcase at the 2023 ACC congress
Acarix, a leader in acoustic and AI-based cardiac diagnostics, will demonstrate the value of its CADScor System during the American Col...
Acarix receives breakthrough order from US Veterans Health Administration
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the first order from the US Veterans Health Administrati...
Invitation to presentation of Acarix´s fourth quarter report
Acarix will publish its fourth quarter results on Thursday 16 February 2023 at 08.00 am (CEST). A live webcast will be held at 11.00 (C...
Acarix AB (publ) publishes Year-End Report 2022
Strategic shift towards full commercial focus on the US market now in placeAs we sum up 2022, it becomes clear that Acarix has in a sho...
Acarix strengthens US Commercial Team
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the appointment of two additional members of the Acarix ...
Acarix is attending 2023 BIO CEO & Investor Conference
Acarix, a leader in innovative acoustic and AI-based cardiac diagnostics, will be attending for the first time the 25th annual BIO CEO ...
Acarix CEO on the company’s US initiative for increased growth
Acarix is in full swing with the launch of CADScor System, an acoustic and AI-based technology for the diagnosis of cardiovascular dise...
Helen Ljungdahl Round, CEO of Acarix Presents at Redeye Life Science Day 2022
On November 24th at 14.50 CET, Helen Ljungdahl Round, CEO of Acarix presented at Redeye Life Science Day 2022. The presentation showcas...
Article published: Improved pre-test likelihood estimation of coronary artery disease using phonocardiography
Article published by PhD student, Bjarke Skogstad Larsen from Acarix: Improved pre-test likelihood estimation of coronary artery diseas...